Scientists at Fred Hutchinson Cancer Research Centre,
Seattle have uncovered a new test that might detect the earliest signs of
cancer which would make treatment more effective.
The test focuses on scraps of genetic material called
microRNAs, which are released into the blood by cancer cells. "Current
technology for developing tests to measure microRNAs in clinical samples is
quite advanced, whereas the bottleneck for developing protein-based biomarkers
is the slow process of generating assays for measuring specific proteins,"
lead author Dr Muneesh Tewari told the Daily Telegraph.
Advertisement
The researchers are now examining the exact microRNAs that determine the presence of specific cancer. "MicroRNAs, which weren't previously thought of as markers of cancer in the blood, are a worthwhile class of molecules to study for the purpose of early cancer detection," Dr Tewari said.
The details of the study appear in the Proceedings of the
National Academy of Sciences.
Source: Medindia
RAS/L
Source: Medindia
RAS/L
Women and Cancer
Cancer is one of the frequently talked about and most feared disease that falls under the genre of lifestyle diseases that have evolved, rather rapidly, in the past two decades.
Advertisement
Advertisement
|
Advertisement
Recommended Reading
Latest Research News
Decoding the eight factors affecting Black adults' life expectancy.
Sobering truth about foot travel in the United States emerges from international statistics, highlighting the prevalence of walking on the Blacksburg campus.
Unveiling a hidden mechanism, proteins within brain cells exhibit newfound abilities at synapses, reinforcing Darwin's theory of adaptation and diversity in the natural world.
Combining micro-needling and cupping, two emerging and alternative techniques, in an experimental study reveals a potential synergy for skin rejuvenation.
Despite a decline in COVID-19 cases, the World Health Organisation (WHO) raises global concerns by warning of an "inevitable" next pandemic known as "Disease X".